MANNKIND CORP MNKD

Latest FY: 2025 Healthcare Biotechnology
Market Price $3.85
Market Cap $1.15B
P/E Ratio 192.25
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑22.2% YoY
$348.97M
3-Yr CAGR: 51.8%
Net Income ↓-78.7% YoY
$5.86M
Net Margin: 1.7%
Free Cash Flow ↓-58.3% YoY
$13.69M
FCF Yield: 1.19%
EPS (Diluted) ↓-80.0% YoY
$0.02
Basic: $0.02
Return on Equity Efficiency
N/A
ROA: 12.6%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MNKD)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $174.8M $157.6M $125.7M $1.36 $-78.1M $-79.2M
FY 2017 $11.7M -93.3% $-5.5M $-117.3M -193.4% $-1.13 -183.1% $-64.8M $-65.9M +16.8%
FY 2018 $27.9M +137.2% $8.5M $-87.0M +25.9% $-0.60 +46.9% $-37.7M $-38.1M +42.2%
FY 2019 $63.0M +126.3% $43.0M $-51.9M +40.3% $-88.5M $-91.0M -139.1%
FY 2020 $65.1M +3.3% $50.1M $-57.2M -10.3% $-28.1M $-28.9M +68.2%
FY 2021 $75.4M +15.8% $58.6M $-80.9M -41.4% $-61.7M $-73.2M -152.9%
FY 2022 $99.8M +32.2% $83.8M $-87.4M -8.0% $-0.34 $-80.7M $-88.3M -20.6%
FY 2023 $199.0M +99.4% $178.1M $-11.9M +86.3% $-0.04 +88.2% $34.1M $-8.3M +90.5%
FY 2024 $285.5M +43.5% $268.1M $27.6M +331.1% $0.10 +350.0% $42.5M $32.8M +493.2%
FY 2025 $349.0M +22.2% $322.2M $5.9M -78.7% $0.02 -80.0% $18.3M $13.7M -58.3%
$

Valuation

Market Price $3.85
Market Cap $1.15B
Enterprise Value $1.43B
P/E Ratio 192.25
P/B Ratio N/A
FCF Yield 1.19%
Dividend Yield N/A
Shares Outstanding 308,950,200
%

Profitability & Margins

Gross Margin 92.32%
Operating Margin 11.12%
Net Margin 1.68%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) 12.59%
Asset Turnover 7.50x
Revenue 3-Yr CAGR 51.80%
🛡️

Financial Health & Liquidity

Current Ratio 0.72
Cash Ratio 1.16
Debt / Equity -6.951
Debt / Assets 7.618
Cash & Equivalents $74.88M
Total Debt $354.64M
Book Value / Share $-0.17
💧

Cash Flow Efficiency

Operating Cash Flow $18.25M
Capital Expenditures (CapEx) $4.57M
Free Cash Flow $13.69M
OCF / Revenue 5.23%
FCF / Revenue 3.92%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $0.02
EPS (Basic) $0.02
Dividends / Share N/A
Book Value / Share $-0.17
EPS YoY Growth -80.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $46.55M
Total Liabilities $64.63M
Stockholders' Equity -$51.02M
Current Assets $46.55M
Current Liabilities $64.63M